阿尔多斯特或矿物质皮质类受体过度表达对视网膜炎症的差异效应
Bastien Leclercq1, Dan Mejlachowicz1, Linxin Zhu1
1Centre de Recherche des Cordeliers, Inserm UMRS1138, Université Paris Cité, Sorbonne Université, Paris, France.
Investigative ophthalmology & visual science
|October 25, 2024
概括
矿物质皮质醇受体 (MR) 的过度活化导致眼睛疾病. 阿尔多斯特注射会引起显著的视网膜炎症,而MR过度表达会导致低度炎症和神经病变,揭示出不同的病理途径.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 矿物质皮质类受体 (MR) 的过度活化与糖尿病视网膜病变和与年龄相关的黄斑变性病原体有关.
- 阿尔多斯特是一种MR配体,在外组织中刺激促炎性细胞因子.
- 皮质醇是主要的眼睛MR配体,作为一种抗炎性葡萄皮质激素.
研究的目的:
- 为了研究MR激活在视网膜炎症中的作用.
- 为了比较急性阿尔多素注射与视网膜MR受体过度表达的影响.
主要方法:
- 在急性眼内阿尔多斯特注射后,在老鼠身上进行视网膜转录组分析.
- 在转基因大鼠过度表达人类MR (hMR) 的视网膜的转录和组织学评估.
主要成果:
- 急性阿尔多素注射诱导了显著的视网膜炎症,激活了微质激活,氧化应激和细胞死亡的途径.
- hMR过度表达导致了低度的视网膜炎症,伴随着胆道炎症和神经病变.
- 在阿尔多素注射和hMR过度表达之间观察到不同的转录组形状,调节基因的重叠有限.
结论:
- 阿尔多斯特在视网膜中具有高度的促炎作用,与其生理背景下的MR过度激活的影响不同.
- 在其生理环境中的MR过度激活导致神经视网膜的低级炎症.
- 阿尔多斯特注射和hMR过度表达触发了视网膜中的不同的病理机制.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
499
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
499
Antihypertensive Drugs: Angiotensin II Receptor Blockers
592
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
592
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Adrenergic Receptors: β Subtype
1.5K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.5K
Antihypertensive Drugs: Action of β1 Blockers
310
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
310
Hormonal Regulation
33.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.0K


